X0609 4 2026-04-01 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001892413 Kuriakose Emil false C/O TERNS PHARMACEUTICALS, INC. 1065 E. HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 false true false false Chief Medical Officer false Common Stock 2026-04-01 4 S false 942.00 52.7526 D 105673.00 D Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person. This sale price represents the weighted average sale price of the shares sold ranging from $52.735 to $52.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ David Strauss, as Attorney-in-Fact for Emil Kuriakose 2026-04-02